NCT06342596View on ClinicalTrials.gov

A Study of Carbon-14-Labelled [14C] LY3473329 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

March 5, 2024

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions

Healthy

Interventions

DRUG

[14C]-LY3473329

Administered orally

DRUG

[14C]-LY3473329

Administered IV

DRUG

LY3473329

Administered orally

Trial Locations (1)

LS11 9EH

Fortrea Clinical Research Unit, Holbeck

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY